Skyline Venture Management IV, LLC's Net Worth
-$12.1 Million
Who is Skyline Venture Management IV, LLC?
Skyline Venture Management IV, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, Targanta Therapeutics Corp., CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, and ACELRX PHARMACEUTICALS INC.
SEC CIK
Skyline Venture Management IV, LLC's CIK is 0001392103
Past Insider Trading and Trends
2011 was Skyline Venture Management IV, LLC's most active year for acquiring shares with 10 total transactions. Skyline Venture Management IV, LLC's most active month to acquire stocks was the month of January. 2014 was Skyline Venture Management IV, LLC's most active year for disposing of shares, totalling 13 transactions. Skyline Venture Management IV, LLC's most active month to dispose stocks was the month of January. 2011 saw Skyline Venture Management IV, LLC paying a total of $6,179,715.00 for 4,090,244 shares, this is the most they've acquired in one year. In 2014 Skyline Venture Management IV, LLC cashed out on 24,851,623 shares for a total of $560,380.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.49% | -295.51K |
—
|
—
| 1.89M |
Mar 12
| |||
Form 4
| +21,071.05% | 2.18M |
$7.00 |
—
| 2.19M |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELRX PHARMACEUTICALS INC (ACRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -31.16% | -1.30M |
—
|
—
| 2.87M |
Mar 7
| |||
Form 4
| +7.34% | 284.7K |
$3.40 | $967,973.20 | 4.16M |
May 29
| |||
Form 4
| +147.17% | 3.89M |
$5.00 | $6,179,715.00 | 6.53M |
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Targanta Therapeutics Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.22M |
—
|
—
|
0
|
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONCERT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,634.46% | 1.18M |
$14.00 |
—
| 1.21M |
Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROTEON THERAPEUTICS INC (TARA) Snapshot price: $2.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.43M |
$8.98 | -$560,380.00 | 1.43M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||